Amgen, Allergan launch first anti-cancer biosims in U.S.

Amgen and Allergan have announced the launch of Mvasi, a bevacizumab biosimilar referencing Avastin, and Kanjinti, a trastuzumab biosimilar referencing Herceptin, in the United States.
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news